View Older Stories View More Recent Stories
-
Stamps.com (STMP) Upside Could be Capped in NT Says Roth, Remains Buy Rated
-
Roth Positive Pixelworks (PXLW), Says Xiamoi Iris Win is Significcan on Multiple Fronts
-
Roth Capital Remains Sidelined on IMAX Corp. (IMAX) Following 1Q Preview
-
DIGITAL ALLY, INC. ANNOUNCES 2017 OPERATING RESULTS
-
DIGITAL ALLY, INC. ANNOUNCES 2017 OPERATING RESULTS
-
Daqo New Energy (DQ) Prices 2M ADS Registered Follow-On Offering at $55/ADS
-
Daqo New Energy Corp. Announces Pricing of Registered Follow-on Offering of American Depositary Shares
-
Sierra Metals Inc. (SMTS) PT Raised to $4.25 at Roth Capital Following Production Announcement
-
Daqo New Energy (DQ) to Offer 2M ADSs
-
Daqo New Energy Corp. Announces Proposed Follow-on Public Offering of American Depositary Shares
-
Intec Pharma (NTEC) Prices 6.75M Offering at $5.25/Share
-
Intec Pharma Announces Pricing of $35.4 Million Public Offering of Ordinary Shares
-
Roth Capital Starts Aptevo Therapeutics (APVO) at Buy
-
Roth Capital Reiterates Buy Radisys Corp (RSYS) Following 1Q Pre-Announcement
-
Roth Capital Downgrades vTv Therapeutics (VTVT) to Neutral
-
Roth Capital Reiterates Buy on Fitbit (FIT) Following Early Versa Reviews
-
Roth Capital Reiterates Buy on ORBCOMM (ORBC) Following Equity Offering
-
Roth Capital Downgrades PetroQuest (PQ) to Neutral
-
Torchlight Energy Announces Plan to Market Midland Basin Assets
-
Roth Capital Reiterates Buy on Ligand Pharma (LGND)
-
Franklin Covey (FC) PT Raised to $34 at Roth Capital
-
Acuity Brands (AYI) PT Lowered to $90 at Roth Capital
-
Roth Capital Assumes Paramount Gold and Silver (PZG) at Buy
-
Clean Diesel Technologies (CDTI) PT Lowered to $0.85 at Roth Capital
-
Digital Ally Announces Pricing of Financing
-
Digital Ally Announces Pricing of Financing
-
Roth Capital Reiterates Buy on Quest Resource Holding (QRHC) Following 4Q
-
Pioneer Power Solutions (PPSI) PT Lowered to $7.50 at Roth Capital Citing Soft Outlook
-
One Stop Systems to Present at the 30th Annual ROTH Conference on March 12, 2018
-
Kempharm (KMPH) PT Raised to $9.50 at Roth Capital Citing Apadaz Approval
-
Acuity Brands (AYI) PT Lowered to $105 at Roth Capital
-
UPDATE: Roth Capital Upgrades Wynn Resorts (WYNN) to Buy
-
Acuity Brands (AYI) PT Lowered to $105 at Roth Capital
-
XpresSpa Group Inc (XSPA) PT Lowered to $2 at Roth Capital
-
Roth Capital Starts New York & Co (NWY) at Buy
-
Roth Capital Starts Allena Pharmaceuticals (ALNA) at Buy, $61 Target, 'Significantly Undervalued'
-
JinkoSolar Holding Co., Ltd. (JKS) PT Lowered to $19 at Roth Capital Following 4Q
-
Shotspotter (SSTI): Muni Contract Wins And Federal Budget Drive PT To $36 - Roth
-
Roth Capital Upgrades Sierra Wireless (SWIR) to Buy Citing Valuation/IoT Opportunities, Says Concerns are Discounted
-
Roth Capital Downgrades NovaBay Pharmaceuticals (NBY) to Neutral
-
Roth Capital Remains Bullish on TPI Composites, Inc. (TPIC) Following Announced Contract Win
-
Auryn Resources Announces Closing of US$9.8 Million Financing
-
SMART Global Holdings (SGH) PT Raised to $70 at Roth Capital Following 2Q
-
iPass Inc. (IPAS) PT Maintained at $2 at Roth Capital; 'WiFi Continues to Grow as Percentage of Traffic'
-
Roth Capital Downgrades Cogentix Medical (CGNT) to Neutral Following Acquisition
-
Gaiam (GAIA) Prices 2.33M Offering of Class A Common Stock at $15/Share
-
Gaia Announces Pricing of Public Offering of Class A Common Stock
-
AIT Therapeutics (AITB) PT Lowered to $13 at Roth Capital; '4Q17 Recap - PPHN the Focus'
-
Trump Tariffs Present Overhang for Chinese Solar Names - Roth
-
GlycoMimetics (GLYC) Prices 7M Share Common Offering at $17/Sh

